A number of other brokerages have also recently weighed in on ASH. Stifel Nicolaus lifted their price objective on shares of Ashland from $143.00 to $148.00 in a research note on Friday, September 23rd. Credit Suisse Group boosted their price objective on shares of Ashland from $120.00 to $125.00 and gave the company an “outperform” rating in a research report on Tuesday, November 8th. Mizuho increased their price objective on Ashland from $138.00 to $139.00 and gave the stock a “buy” rating in a report on Tuesday, July 19th. Wells Fargo & Company upped their price target on Ashland from $104.00 to $118.00 and gave the stock an “equal weight” rating in a research note on Wednesday, November 9th. Finally, UBS Group raised their price target on Ashland from $127.00 to $131.00 and gave the company a “buy” rating in a research report on Wednesday, July 27th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, Ashland presently has an average rating of “Moderate Buy” and a consensus target price of $126.56.
Ashland Stock Performance
Ashland stock opened at $111.68 on Wednesday. Ashland has a 52 week low of $83.29 and a 52 week high of $112.91. The company has a current ratio of 3.20, a quick ratio of 2.06 and a debt-to-equity ratio of 0.39. The stock has a market cap of $6.05 billion, a P/E ratio of 6.89 and a beta of 1.00. The stock has a 50 day moving average of $100.19 and a 200-day moving average of $101.66.
Institutional Inflows and Outflows
Ashland Company Profile
Ashland Inc provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
- Get a free copy of the StockNews.com research report on Ashland (ASH)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
- Three Penny Stocks Making Big Moves In November
Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.